scholarly journals A Long Term Analysis of The Clinical And Cost Effectiveness of Glatiramer Acetate From The Uk Multiple Sclerosis Risk Sharing Scheme

2015 ◽  
Vol 18 (7) ◽  
pp. A765-A766 ◽  
Author(s):  
M Sumra ◽  
E Walters
Keyword(s):  
Multiple Sclerosis ◽  
Cost Effectiveness ◽  
Glatiramer Acetate ◽  
Risk Sharing ◽  
Multiple Sclerosis Risk ◽  
Sharing Scheme ◽  
The Uk ◽  
Term Analysis

Continuing the multiple sclerosis risk sharing scheme is unjustified

BMJ ◽  
2010 ◽  
Vol 340 (jun03 1) ◽  
pp. c1786-c1786 ◽  
Author(s):  
C. McCabe ◽  
J. Chilcott ◽  
K. Claxton ◽  
P. Tappenden ◽  
C. Cooper ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Risk Sharing ◽  
Multiple Sclerosis Risk ◽  
Sharing Scheme

The multiple sclerosis risk sharing scheme

BMJ ◽  
2010 ◽  
Vol 340 (jun03 1) ◽  
pp. c2882-c2882 ◽  
Author(s):  
N. Scolding
Keyword(s):  
Multiple Sclerosis ◽  
Risk Sharing ◽  
Multiple Sclerosis Risk ◽  
Sharing Scheme

scholarly journals The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future

BMC Neurology ◽  
2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Mark Pickin ◽  
Cindy L Cooper ◽  
Timothy Chater ◽  
Anthony O'Hagan ◽  
Keith R Abrams ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Risk Sharing ◽  
Multiple Sclerosis Risk ◽  
Sharing Scheme ◽  
Early Results ◽  
Monitoring Study ◽  
The Future
Sign in / Sign up

Export Citation Format

Share Document